June 29 (Reuters) - TBG Diagnostics Ltd (TDL) : TBG to acquire controlling equity stake in RBC Biosciences TBG to acquire 51% of RBC Biosciences for NT$127 million Addition of RBC is expected to double TBG's annual sales revenues to $A8.1 million
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
